Summary
Ascertain, an AI health care company, appointed Molly O'Neill as its new chief commercial officer. O'Neill's role will focus on expanding the company's client network after successful trials with Northwell Health.
Key Facts
- Ascertain hired Molly O'Neill as chief commercial officer.
- O'Neill was previously with Aegis Ventures and Duke Health.
- Her task is to grow Ascertain’s client base after trials at Northwell Health.
- Ascertain is a spin-off from Northwell Health and Aegis Ventures.
- The company raised $10 million in a Series A funding round in May.
- Mark Michalski from Deerfield Management is CEO of Ascertain.
- Ascertain's solutions reduced clicks by 80% and authorization time by 67%.
- O'Neill is on the boards of Mauna Kea Technologies, Curative Strategy Group, and myLaurel.
